Checkpoint Therapeutics I... (CKPT)

AI Score

Unlock

4.08

0.04 (0.99%)

At close: Apr 24, 2025, 3:59 PM

4.09

0.12%

After-hours: Apr 24, 2025, 04:05 PM EDT

Checkpoint Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-28.9M	-9.72M	-6.67M	-10.95M	-19.13M	-5.72M	-16.52M	-10.47M	-21.02M	-10.61M	-14.14M	-16.85M	-29.76M	-11.27M	-9.14M	-6.5M	-10.22M	-4.93M	-4.64M	-3.28M	-8.83M	-5.21M	-4.79M	-5.89M	-11.62M	-9.34M	-6.64M	-8.77M	-5.92M	-5.93M	-6.45M	-4.38M	-8.32M	-5.13M	-5.41M	-3.6M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	324K	n/a	n/a	n/a
Stock-Based Compensation	11.76M	1.61M	567K	709K	672K	689K	567K	969K	639K	781K	729K	775K	818K	779K	766K	774K	685K	725K	731K	639K	677K	833K	813K	798K	-342K	1.13M	72K	1.14M	-1.15M	910K	2.38M	979K	1.22M	760K	803K	1.09M
Other Working Capital	1.97M	185K	-741K	-284K	-35K	471K	129K	-2.17M	3.19M	84K	3.53M	-437K	-6.01M	3.98M	2.42M	427K	718K	-1.44M	1.69M	-836K	5.41M	795K	-1.07M	1.76M	-4.11M	1.58M	36K	622K	-2.12M	1.21M	-1.01M	-19K	-2.96M	1.47M	881K	-48K
Other Non-Cash Items	7.99M	-471K	604K	-2.54M	12.52M	-1.72M	759K	-7.41M	6.51M	26K	17K	196K	6.71M	39K	253K	634K	4.72M	731K	66K	-1.06M	3.05M	92K	97K	9K	1.75M	174K	-875K	641K	2.3M	1.74M	400K	979K	4.02M	1M	2.06M	338K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-324K	n/a	n/a	n/a
Change in Working Capital	1.97M	-2.63M	-741K	3.37M	-901K	-8M	3.22M	2.88M	-1.43M	-1.61M	2.17M	-3.73M	12.76M	3.98M	2.42M	440K	-115K	-1.44M	1.69M	-1.9M	370K	795K	-1.07M	-3.12M	2.61M	1.58M	36K	1.78M	583K	1.21M	-1.01M	616K	-1.08M	1.47M	881K	-48K
Operating Cash Flow	-7.18M	-11.21M	-6.24M	-6.47M	-6.83M	-14.75M	-11.98M	-14.03M	-15.3M	-11.42M	-11.23M	-19.61M	-9.48M	-6.46M	-5.71M	-4.66M	-4.93M	-4.92M	-2.16M	-4.54M	-4.73M	-3.49M	-4.96M	-8.2M	-7.61M	-6.46M	-6.53M	-5.21M	-4.19M	-3.81M	-4.67M	-2.79M	-4.17M	-1.89M	-1.66M	-2.23M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-100K	-1M	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-400K	n/a	-400K	n/a	-100K	-1M	-2.06M	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-400K	n/a	-400K	n/a	-100K	-1M	-2.06M	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.79M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.69M	n/a	n/a	-1.7M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-6.32M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.08M	-1.04M	-50K	-1.21M	9.99M	-899K	-1.57M	-691K	-2.48M	-21K	-59K	-164K	-82K	-31K	-246K	-651K	-406K	-1.5M	-62K	-56K	-1.92M	-80K	-105K	-10K	30.99M	-223K	-28K	-2.17M	n/a	n/a	n/a	n/a	2.79M	n/a	6.32M	570K
Financial Cash Flow	9.08M	10.96M	-50K	12.79M	9.99M	9.1M	14.55M	6.81M	6.89M	1.01M	642K	6.35M	4.01M	1.54M	10.8M	23.92M	3.68M	25.02M	2.6M	-56K	17.75M	3.34M	4.01M	355K	n/a	7.76M	-28K	20.84M	n/a	n/a	n/a	n/a	-5.58M	n/a	n/a	-2.22M
Net Cash Flow	1.9M	-248K	-6.29M	6.31M	3.16M	-5.65M	2.58M	-7.22M	-8.41M	-10.41M	-10.59M	-13.26M	-5.47M	-4.92M	5.09M	19.26M	-1.26M	20.11M	443K	-4.6M	13.02M	-145K	-942K	-7.85M	-7.61M	1.3M	-6.56M	15.64M	-4.19M	-3.81M	-5.07M	-2.79M	-4.27M	-2.89M	-3.72M	-4.45M
Free Cash Flow	-7.18M	-11.21M	-6.24M	-6.47M	-6.83M	-14.75M	-11.98M	-14.03M	-15.3M	-11.42M	-11.23M	-19.61M	-9.48M	-6.46M	-5.71M	-4.66M	-4.93M	-4.92M	-2.16M	-4.54M	-4.73M	-3.49M	-4.96M	-8.2M	-7.61M	-6.46M	-6.53M	-5.21M	-4.19M	-3.81M	-4.67M	-2.79M	-4.27M	-2.89M	-1.66M	-2.23M